Greenland Mines Ltd. Common Stock (NASDAQ:GRML) Issues Earnings Results

Posted by Stanley Muller on May 21st, 2026

Greenland Mines Ltd. Common Stock (NASDAQ:GRML – Get Free Report) released its earnings results on Wednesday. The company reported ($0.15) earnings per share for the quarter, FiscalAI reports.

Greenland Mines Ltd. Common Stock Trading Up 14.8%

NASDAQ:GRML opened at $0.39 on Thursday. Greenland Mines Ltd. Common Stock has a 1 year low of $0.16 and a 1 year high of $3.91. The firm has a 50 day moving average of $0.49 and a 200-day moving average of $0.42. The stock has a market capitalization of $47.10 million, a P/E ratio of -1.21 and a beta of 7.61.

Analyst Upgrades and Downgrades

GRML has been the subject of a number of analyst reports. Wall Street Zen upgraded shares of Greenland Mines Ltd. Common Stock to a “sell” rating in a research note on Saturday, May 2nd. Weiss Ratings restated a “sell (e+)” rating on shares of Greenland Mines Ltd. Common Stock in a research note on Wednesday, April 22nd. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, Greenland Mines Ltd. Common Stock has an average rating of “Sell”.

Get Our Latest Stock Report on GRML

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the company. XTX Topco Ltd raised its stake in shares of Greenland Mines Ltd. Common Stock by 101.2% in the fourth quarter. XTX Topco Ltd now owns 160,569 shares of the company’s stock valued at $46,000 after acquiring an additional 80,768 shares during the last quarter. Jane Street Group LLC bought a new position in shares of Greenland Mines Ltd. Common Stock in the fourth quarter valued at approximately $64,000. Renaissance Technologies LLC bought a new position in shares of Greenland Mines Ltd. Common Stock in the fourth quarter valued at approximately $126,000. Geode Capital Management LLC raised its stake in shares of Greenland Mines Ltd. Common Stock by 51.8% in the fourth quarter. Geode Capital Management LLC now owns 491,832 shares of the company’s stock valued at $142,000 after acquiring an additional 167,905 shares during the last quarter. Finally, Brummer Multi Strategy AB bought a new position in shares of Greenland Mines Ltd. Common Stock in the fourth quarter valued at approximately $175,000. Institutional investors own 20.07% of the company’s stock.

Greenland Mines Ltd. Common Stock Company Profile

(Get Free Report)

Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases – cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.